Recently, Neugebauer et al. included 127,600 insulin-naïve adults with T2D at the 4 U.S. health care delivery systems to examine the association of using human insulin only (HI group) versus analogue insulin with or without human insulin (AI group) with mortality and major cardiovascular events. The gene discussed is INS; the disease is type 2 diabetes mellitus.